Metabolomic profiling distinction of human nonalcoholic fatty liver disease progression from a common rat model

Jian Hua Han, Anika L. Dzierlenga, Zhengqiang Lu, David D Billheimer, Elmira Torabzadeh, April D. Lake, Hui Li, Petr Novak, Petia Shipkova, Nelly Aranibar, Donald Robertson, Michael D. Reily, Lois D. Lehman-McKeeman, Nathan J Cherrington

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Objective: Characteristic pathological changes define the progression of steatosis to nonalcoholic steatohepatitis (NASH) and are correlated to metabolic pathways. A common rodent model of NASH is the methionine and choline deficient (MCD) diet. The objective of this study was to perform full metabolomic analyses on liver samples to determine which pathways are altered most pronouncedly in this condition in humans, and to compare these changes to rodent models of nonalcoholic fatty liver disease (NAFLD). Methods: A principal component analysis for all 91 metabolites measured indicated that metabolome perturbation is greater and less varied for humans than for rodents. Results: Metabolome changes in human and rat NAFLD were greatest for the amino acid and bile acid metabolite families (e.g., asparagine, citrulline, gamma-aminobutyric acid, lysine); although, in many cases, the trends were reversed when compared between species (cholic acid, betaine). Conclusions: Overall, these results indicate that metabolites of specific pathways may be useful biomarkers for NASH progression, although these markers may not correspond to rodent NASH models. The MCD model may be useful when studying certain end points of NASH; however, the metabolomics results indicate important differences between humans and rodents in the biochemical pathogenesis of the disease.

Original languageEnglish (US)
Pages (from-to)1069-1076
Number of pages8
JournalObesity
Volume25
Issue number6
DOIs
StatePublished - Jun 1 2017

Fingerprint

Metabolomics
Disease Progression
Rodentia
Metabolome
Choline
Methionine
Cholic Acid
Betaine
Citrulline
Asparagine
Metabolic Networks and Pathways
Non-alcoholic Fatty Liver Disease
Principal Component Analysis
Bile Acids and Salts
gamma-Aminobutyric Acid
Lysine
Biomarkers
Diet
Amino Acids
Liver

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Endocrinology, Diabetes and Metabolism
  • Endocrinology
  • Nutrition and Dietetics

Cite this

Metabolomic profiling distinction of human nonalcoholic fatty liver disease progression from a common rat model. / Han, Jian Hua; Dzierlenga, Anika L.; Lu, Zhengqiang; Billheimer, David D; Torabzadeh, Elmira; Lake, April D.; Li, Hui; Novak, Petr; Shipkova, Petia; Aranibar, Nelly; Robertson, Donald; Reily, Michael D.; Lehman-McKeeman, Lois D.; Cherrington, Nathan J.

In: Obesity, Vol. 25, No. 6, 01.06.2017, p. 1069-1076.

Research output: Contribution to journalArticle

Han, JH, Dzierlenga, AL, Lu, Z, Billheimer, DD, Torabzadeh, E, Lake, AD, Li, H, Novak, P, Shipkova, P, Aranibar, N, Robertson, D, Reily, MD, Lehman-McKeeman, LD & Cherrington, NJ 2017, 'Metabolomic profiling distinction of human nonalcoholic fatty liver disease progression from a common rat model', Obesity, vol. 25, no. 6, pp. 1069-1076. https://doi.org/10.1002/oby.21855
Han, Jian Hua ; Dzierlenga, Anika L. ; Lu, Zhengqiang ; Billheimer, David D ; Torabzadeh, Elmira ; Lake, April D. ; Li, Hui ; Novak, Petr ; Shipkova, Petia ; Aranibar, Nelly ; Robertson, Donald ; Reily, Michael D. ; Lehman-McKeeman, Lois D. ; Cherrington, Nathan J. / Metabolomic profiling distinction of human nonalcoholic fatty liver disease progression from a common rat model. In: Obesity. 2017 ; Vol. 25, No. 6. pp. 1069-1076.
@article{92b1aa2d541944fd9cbfa86cbd6860ea,
title = "Metabolomic profiling distinction of human nonalcoholic fatty liver disease progression from a common rat model",
abstract = "Objective: Characteristic pathological changes define the progression of steatosis to nonalcoholic steatohepatitis (NASH) and are correlated to metabolic pathways. A common rodent model of NASH is the methionine and choline deficient (MCD) diet. The objective of this study was to perform full metabolomic analyses on liver samples to determine which pathways are altered most pronouncedly in this condition in humans, and to compare these changes to rodent models of nonalcoholic fatty liver disease (NAFLD). Methods: A principal component analysis for all 91 metabolites measured indicated that metabolome perturbation is greater and less varied for humans than for rodents. Results: Metabolome changes in human and rat NAFLD were greatest for the amino acid and bile acid metabolite families (e.g., asparagine, citrulline, gamma-aminobutyric acid, lysine); although, in many cases, the trends were reversed when compared between species (cholic acid, betaine). Conclusions: Overall, these results indicate that metabolites of specific pathways may be useful biomarkers for NASH progression, although these markers may not correspond to rodent NASH models. The MCD model may be useful when studying certain end points of NASH; however, the metabolomics results indicate important differences between humans and rodents in the biochemical pathogenesis of the disease.",
author = "Han, {Jian Hua} and Dzierlenga, {Anika L.} and Zhengqiang Lu and Billheimer, {David D} and Elmira Torabzadeh and Lake, {April D.} and Hui Li and Petr Novak and Petia Shipkova and Nelly Aranibar and Donald Robertson and Reily, {Michael D.} and Lehman-McKeeman, {Lois D.} and Cherrington, {Nathan J}",
year = "2017",
month = "6",
day = "1",
doi = "10.1002/oby.21855",
language = "English (US)",
volume = "25",
pages = "1069--1076",
journal = "Obesity",
issn = "1930-7381",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - Metabolomic profiling distinction of human nonalcoholic fatty liver disease progression from a common rat model

AU - Han, Jian Hua

AU - Dzierlenga, Anika L.

AU - Lu, Zhengqiang

AU - Billheimer, David D

AU - Torabzadeh, Elmira

AU - Lake, April D.

AU - Li, Hui

AU - Novak, Petr

AU - Shipkova, Petia

AU - Aranibar, Nelly

AU - Robertson, Donald

AU - Reily, Michael D.

AU - Lehman-McKeeman, Lois D.

AU - Cherrington, Nathan J

PY - 2017/6/1

Y1 - 2017/6/1

N2 - Objective: Characteristic pathological changes define the progression of steatosis to nonalcoholic steatohepatitis (NASH) and are correlated to metabolic pathways. A common rodent model of NASH is the methionine and choline deficient (MCD) diet. The objective of this study was to perform full metabolomic analyses on liver samples to determine which pathways are altered most pronouncedly in this condition in humans, and to compare these changes to rodent models of nonalcoholic fatty liver disease (NAFLD). Methods: A principal component analysis for all 91 metabolites measured indicated that metabolome perturbation is greater and less varied for humans than for rodents. Results: Metabolome changes in human and rat NAFLD were greatest for the amino acid and bile acid metabolite families (e.g., asparagine, citrulline, gamma-aminobutyric acid, lysine); although, in many cases, the trends were reversed when compared between species (cholic acid, betaine). Conclusions: Overall, these results indicate that metabolites of specific pathways may be useful biomarkers for NASH progression, although these markers may not correspond to rodent NASH models. The MCD model may be useful when studying certain end points of NASH; however, the metabolomics results indicate important differences between humans and rodents in the biochemical pathogenesis of the disease.

AB - Objective: Characteristic pathological changes define the progression of steatosis to nonalcoholic steatohepatitis (NASH) and are correlated to metabolic pathways. A common rodent model of NASH is the methionine and choline deficient (MCD) diet. The objective of this study was to perform full metabolomic analyses on liver samples to determine which pathways are altered most pronouncedly in this condition in humans, and to compare these changes to rodent models of nonalcoholic fatty liver disease (NAFLD). Methods: A principal component analysis for all 91 metabolites measured indicated that metabolome perturbation is greater and less varied for humans than for rodents. Results: Metabolome changes in human and rat NAFLD were greatest for the amino acid and bile acid metabolite families (e.g., asparagine, citrulline, gamma-aminobutyric acid, lysine); although, in many cases, the trends were reversed when compared between species (cholic acid, betaine). Conclusions: Overall, these results indicate that metabolites of specific pathways may be useful biomarkers for NASH progression, although these markers may not correspond to rodent NASH models. The MCD model may be useful when studying certain end points of NASH; however, the metabolomics results indicate important differences between humans and rodents in the biochemical pathogenesis of the disease.

UR - http://www.scopus.com/inward/record.url?scp=85018353953&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85018353953&partnerID=8YFLogxK

U2 - 10.1002/oby.21855

DO - 10.1002/oby.21855

M3 - Article

C2 - 28452429

AN - SCOPUS:85018353953

VL - 25

SP - 1069

EP - 1076

JO - Obesity

JF - Obesity

SN - 1930-7381

IS - 6

ER -